1. Ketalar labelling in Canada now includes hepatobiliary toxicity risk

   News item 22 May 2021 Pages: 1 - 1

2. Levetiracetam-related QT interval prolongation

   News item 22 May 2021 Pages: 2 - 2

3. Myelodysplastic syndrome or acute myeloid leukaemia with olaparib

   News item 22 May 2021 Pages: 3 - 3

4. PRAC May 2021 meeting highlights: COVID-19 vaccine AEs

   News item 22 May 2021 Pages: 4 - 4

5. Cardiovascular adverse events with VEGFR-TKIs

   Clinical study 22 May 2021 Pages: 5 - 5

6. COVID-19 vaccination during pregnancy: no increase in placental lesions

   Clinical study 22 May 2021 Pages: 6 - 6

7. Do NSAIDs increase the severity of COVID-19?

   Clinical study 22 May 2021 Pages: 7 - 7

8. Does training specialist oncology nurses improve ADR reporting?

   Clinical study 22 May 2021 Pages: 8 - 8

9. Domperidone in pregnancy: congenital anomalies or natural terminations

   Clinical study 22 May 2021 Pages: 9 - 9

10. Medications may be contributing to high blood pressure

    Clinical study 22 May 2021 Pages: 10 - 10

11. Other adverse reaction research

    News item 22 May 2021 Pages: 11 - 11

12. Acalabrutinib

    Case report 22 May 2021 Pages: 12 - 12

13. Acetazolamide

    Case report 22 May 2021 Pages: 13 - 13

14. Acetazolamide/furosemide/topiramate

    Case report 22 May 2021 Pages: 14 - 14

15. Acitretin

    Case report 22 May 2021 Pages: 15 - 15

16. Adenosine

    Case report 22 May 2021 Pages: 16 - 16

17. Adenosine

    Case report 22 May 2021 Pages: 17 - 17

18. Adenosine

    Case report 22 May 2021 Pages: 18 - 18

19. Adenosine/propranolol

    Case report 22 May 2021 Pages: 19 - 19

20. Adenosine/verapamil

    Case report 22 May 2021 Pages: 20 - 20

21. Aflibercept/ranibizumab

    Case report 22 May 2021 Pages: 21 - 21

22. Agomelatine

    Case report 22 May 2021 Pages: 22 - 22

23. Alectinib/crizotinib

    Case report 22 May 2021 Pages: 23 - 23

24. Alemtuzumab

    Case report 22 May 2021 Pages: 24 - 24

25. Alendronic-acid

    Case report 22 May 2021 Pages: 25 - 25

26. Alendronic-acid/risedronic-acid

    Case report 22 May 2021 Pages: 26 - 26

27. Alitretinoin

    Case report 22 May 2021 Pages: 27 - 27

28. Allergy-immunotherapy

    Case report 22 May 2021 Pages: 28 - 28

29. Aloin/atropine/cathine/diazepam/liothyronine

    Case report 22 May 2021 Pages: 29 - 29

30. Alprazolam

    Case report 22 May 2021 Pages: 30 - 30

31. Alteplase/dornase-α

    Case report 22 May 2021 Pages: 31 - 31

32. Amantadine/modafinil

    Case report 22 May 2021 Pages: 32 - 32

33. Amikacin/linezolid

    Case report 22 May 2021 Pages: 33 - 33

34. Amiodarone

    Case report 22 May 2021 Pages: 34 - 34

35. Amiodarone

    Case report 22 May 2021 Pages: 35 - 35

36. Amiodarone

    Case report 22 May 2021 Pages: 36 - 36

37. Amiodarone

    Case report 22 May 2021 Pages: 37 - 37

38. Amiodarone/β-adrenergic-receptor-antagonists/lidocaine

    Case report 22 May 2021 Pages: 38 - 38

39. Amiodarone/caffeine/lidocaine

    Case report 22 May 2021 Pages: 39 - 39

40. Amiodarone/chloroquine/remdesivir interaction

    Case report 22 May 2021 Pages: 40 - 40

41. Amiodarone/ibrutinib

    Case report 22 May 2021 Pages: 41 - 41

42. Amiodarone/lidocaine

    Case report 22 May 2021 Pages: 42 - 42

43. Amiodarone/lidocaine

    Case report 22 May 2021 Pages: 43 - 43

44. Amiodarone/lidocaine

    Case report 22 May 2021 Pages: 44 - 44

45. Amiodarone/lidocaine

    Case report 22 May 2021 Pages: 45 - 45

46. Amiodarone/metoprolol

    Case report 22 May 2021 Pages: 46 - 46

47. Amiodarone/mexiletine/prednisone

    Case report 22 May 2021 Pages: 47 - 47

48. Anakinra

    Case report 22 May 2021 Pages: 48 - 48

49. Anakinra/hydroxycarbamide

    Case report 22 May 2021 Pages: 49 - 49

50. Anisodamine

    Case report 22 May 2021 Pages: 50 - 50